Speech restoration with tracheoesophageal prosthesis after total laryngectomy: An observational study of vocal results, complications and quality of life.


Journal

European annals of otorhinolaryngology, head and neck diseases
ISSN: 1879-730X
Titre abrégé: Eur Ann Otorhinolaryngol Head Neck Dis
Pays: France
ID NLM: 101531465

Informations de publication

Date de publication:
Mar 2022
Historique:
pubmed: 19 6 2021
medline: 9 3 2022
entrez: 18 6 2021
Statut: ppublish

Résumé

To study voice prosthesis survival, complications, efficacy and impact on quality of life. A single-center observational study was performed in patients treated for squamous cell carcinoma of the larynx or hypopharynx by total (pharyngo)-laryngectomy between 2010 and 2015. Study data comprised: maximum phonation time (sec), number of and reasons for prosthesis exchanges (leakage through or around the prosthesis, expulsion or inclusion of the prosthesis), plus 2 quality of life questionnaires (QLQ-C30, QLQ-H&N35) and the Voice Handicap Inventory (VHI 30). Forty-nine patients were included. The most common causes of prosthesis exchange were leakage through (73.2%) or around the prosthesis (18.5%). The median time between exchanges was 4 months. Global quality of life status on the QLQ-C30 was 63.5. Mean maximum phonation time was 7.4sec. Mean VHI was 46/120; 10 patients had a mild voice handicap, 12 moderate and 10 severe. No relation emerged between the number of prosthesis exchanges per year and quality of life. Voice handicap significantly decreased quality of life, with QLQ-C30 72.3 for the 22 patients with mild to moderate voice handicap and 44.2 for the 10 patients with severe voice handicap (P=0.001). Voice restoration by tracheoesophageal prosthesis after total (pharyngo)-laryngectomy is a reliable technique that decreases voice handicap and, despite potentially serious complications, has little negative impact on quality of life.

Identifiants

pubmed: 34140266
pii: S1879-7296(21)00094-6
doi: 10.1016/j.anorl.2021.05.008
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

73-76

Informations de copyright

Copyright © 2021. Published by Elsevier Masson SAS.

Auteurs

V Apert (V)

Service d'ORL, de chirurgie cervico-faciale et d'audiophonologie, CHU de Poitiers, CS90577, 86000 Poitiers, France.

F Carsuzaa (F)

Service d'ORL, de chirurgie cervico-faciale et d'audiophonologie, CHU de Poitiers, CS90577, 86000 Poitiers, France.

D Tonnerre (D)

Service d'ORL, de chirurgie cervico-faciale et d'audiophonologie, CHU de Poitiers, CS90577, 86000 Poitiers, France.

J Leclerc (J)

Service d'ORL, de chirurgie cervico-faciale et d'audiophonologie, CHU de Poitiers, CS90577, 86000 Poitiers, France.

J-P Lebreton (JP)

Service d'ORL, de chirurgie cervico-faciale et d'audiophonologie, CHU de Poitiers, CS90577, 86000 Poitiers, France.

A Delagranda (A)

Service d'ORL et de chirurgie cervico-faciale, CHU Félix-Guyon, 2, allée des Topazes, 97400 Saint-Denis, Reunion.

X Dufour (X)

Service d'ORL, de chirurgie cervico-faciale et d'audiophonologie, CHU de Poitiers, CS90577, 86000 Poitiers, France. Electronic address: xavier.dufour@chu-poitiers.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH